A unique nasal spray designed to combat epileptic seizures could be one of the first medicinal cannabis products to hit Australia’s healthcare market.
Perth-based medical cannabis producer MGC Pharmaceuticals announced on Thursday it has struck a deal with Israeli company SipNose to use nasal spray to administer cannabis.
Sydney cardiologist and MGC director Dr Ross Walker says the product is ready to go once Australian regulatory hurdles are overcome.
Recent changes at a federal level permit legally-grown cannabis for medicinal cannabis products, but the drug remains a prohibited substance.
– Read the entire article at Sydney Morning Herald.